SCHEMBL13853495

SCHEMBL13853495

CNC(=O)NCc1cccc(OC)c1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.67
HTT P42858 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
MMP13 P45452 1/20 0.67
LMNA P02545 2/20 0.64
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
GAA P10253 1/20 0.64
MAPT P10636 1/20 0.64
ALOX15 P16050 1/20 0.64
GFER P55789 1/20 0.64
HSD17B10 Q99714 1/20 0.64
HPGD P15428 3/20 0.60
POLB P06746 1/20 0.60
ROCK2 O75116 1/20 0.60
ANPEP P15144 1/20 0.60
EPHX2 P34913 2/20 0.59
KDM4E B2RXH2 1/20 0.59
USP2 O75604 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3815151 0.92 ALDH1A1 (0.72) ALDH1A1HTTSMN1; SMN2MMP13LMNA
SCHEMBL23771131 0.86 ALDH1A1 (0.65) ALDH1A1HTTSMN1; SMN2MMP13LMNA
SCHEMBL13853575 0.85 CNR1 (0.67) ALDH1A1HTTPOLB
SCHEMBL660541 0.84 MMP13 (0.70) ALDH1A1HTTSMN1; SMN2MMP13LMNA
SCHEMBL2931410 0.84 MMP13 (0.70) ALDH1A1HTTSMN1; SMN2MMP13LMNA
SCHEMBL13306937 0.83 TACR1 (0.52) ALDH1A1HTTSMN1; SMN2MMP13LMNA
SCHEMBL30104666 0.83 ALDH1A1 (0.68) ALDH1A1HTTSMN1; SMN2MMP13LMNA
SCHEMBL18175810 0.83 ALDH1A1 (0.68) ALDH1A1HTTSMN1; SMN2MMP13LMNA
Hydrochloric Acid SCHEMBL29194804 0.83 MMP13 (0.68) ALDH1A1HTTSMN1; SMN2MMP13LMNA
SCHEMBL8245692 0.83 ALDH1A1 (0.68) ALDH1A1HTTSMN1; SMN2MMP13LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354418-B2 Thiazolyl-dihydro-quinazolines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-15 US disclosed
US-20090131424-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-05-21 US disclosed
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-08 US disclosed
US-20070238746-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE ROR1, RORB, RORA ALDH1A1 60/4885HTT 908/4885SMN1; SMN2 3573/4885
US-20070238746-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE CYP3A7, UGT2B7, UGT1A7 ALDH1A1 165/4885HTT 1026/4885SMN1; SMN2 3842/4885
US-20090131424-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE CYP3A7, UGT2B7, UGT1A7 ALDH1A1 165/4885HTT 1026/4885SMN1; SMN2 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.